KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Equity Average: 2018-2025

Historic Equity Average for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $475.6 million.

  • Twist Bioscience's Equity Average fell 1.31% to $475.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $475.6 million, marking a year-over-year decrease of 1.31%. This contributed to the annual value of $472.8 million for FY2025, which is 13.73% down from last year.
  • According to the latest figures from Q3 2025, Twist Bioscience's Equity Average is $475.6 million, which was up 3.58% from $459.2 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Equity Average registered a high of $842.0 million during Q2 2022, and its lowest value of $448.0 million during Q1 2025.
  • For the 3-year period, Twist Bioscience's Equity Average averaged around $553.0 million, with its median value being $525.6 million (2024).
  • In the last 5 years, Twist Bioscience's Equity Average spiked by 240.92% in 2021 and then decreased by 24.76% in 2024.
  • Over the past 5 years, Twist Bioscience's Equity Average (Quarterly) stood at $603.5 million in 2021, then climbed by 27.23% to $767.9 million in 2022, then declined by 20.98% to $606.7 million in 2023, then decreased by 23.47% to $464.3 million in 2024, then declined by 1.31% to $475.6 million in 2025.
  • Its Equity Average stands at $475.6 million for Q3 2025, versus $459.2 million for Q2 2025 and $448.0 million for Q1 2025.